TEMPUS AI INC CLASS A (TEM)
NASDAQ • Healthcare
July 20, 2026 at 20:00 UTC
About TEMPUS AI INC CLASS A
Tempus AI, Inc. (NASDAQ: TEM) provides data-driven diagnostics and software for cancer care and drug development within healthcare information services, combining laboratory testing with clinical data tools. The company generated $1.3 billion in FY2025 revenue and sells its services to care providers, life sciences companies, and research users.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
TEMPUS AI INC CLASS A's Technical Indicators Summary
Terna Energy displays a pronounced downside stance with the current price beneath many short- and long-term averages and the 200-day average above the market, signaling longer-term weakness. Momentum readings are negative and ATR shows above-normal volatility for the stock, while ADX indicates a firm trend presence even as some oscillators remain mixed; OBV is negative, consistent with distribution. The price also sits below the pivot area. Technical takeaway: overall a strong sell profile characterized by downward price alignment, negative momentum, elevated volatility and weak volume flow.
| Indicator | Value |
|---|---|
RSI (14) | 45.54 |
Stochastic %K (14, 3, 3) | 21.30 |
CCI (20) | -74.17 |
WPR (14) | -89.56 |
Momentum (10) | -7.80 |
MFI | 62.90 |
MACD Level (12, 26) | 1.20 |
Bollinger Bands | $47.92 - $64.49 |
ATR (14) | $3.96 (7.56%) |
ADX (14) | 31.50 |
OBV | 94,078,865 |
Classic Pivot Point | $54.72 |
Fibonacci Pivot Point | $54.72 |
Simple Moving Averages | $51.10 - $61.80(5 indicators) |
Exponential Moving Averages | $53.54 - $61.01(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Into the close, TEM remained below water after a -7.74% gap lower versus yesterday. End-of-day sector performance was slightly negative (-1.11%), mildly offsetting stock-specific strength. TEM's $1.7B Personalis deal is labeled a 'market misread' by Needham, signaling a potential re-rating.
Trading Volume
Above 10d avg 4.8M
10.1M
vs S&P 500 Today
Strong Underperformance
-7.68%
52-Week Position
Lower range
10.7%
Updated: July 20, 2026 at 21:03 UTC
Quote Summary
TEM Headlines
Tempus AI to buy Personalis in $1.5bn deal
July 20, 2026